Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study will consist of a single session of MDMA-assisted therapy with a full dose of MDMA
for people who took part in a study of MDMA-assisted therapy in people with posttraumatic
stress disorder (PTSD) whose PTSD symptoms returned to higher levels at least a year after
the first MDMA sessions. The single session will be performed by the same pair of therapists
who performed the sessions in the first study. People will have a preparatory session, the
MDMA-assisted session and three non-drug sessions afterward. Their PTSD symptoms and symptoms
of depression will be measured at the start of this study and two and 12 months after the
session.
Phase:
Phase 2
Details
Lead Sponsor:
Multidisciplinary Association for Psychedelic Studies